HIGHLIGHTS
- What: These case reports describe the treatment of MS that only relapsed 8-10 years after receiving one course of cladribine treatment.
- Who: Miguel Angel Hernandez et al. from the Neurology, Multiple Sclerosis Unit, University Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, ESP have published the Article: Review began 07/30/2024 Review ended 11/25/2024 Published 11/28/2024 © Copyright, in the Journal: (JOURNAL) of November/28,/2024
SUMMARY
Multiple_sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS), characterized by demyelinating . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.